Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 368  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission

    Article Cited by others


Effects of moxonidine on sympathetic nervous system activity: An update on metabolism, cardio, and other target-organ protection

Karlafti Eleni F, Hatzitolios Apostolos I, Karlaftis Anastasios F, Baltatzi Maria S, Koliakos Georgios G, Savopoulos Christos G

Year : 2013| Volume: 5| Issue : 4 | Page no: 253-256

   This article has been cited by
1 Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study
Eleni Karlafti, Triantafyllos Didangelos, Emmanouil Benioudakis, Evangelia Kotzakioulafi, Georgia Kaiafa, Vasileios Kotsis, Antonios Ziakas, Michail Doumas, Antonios Goulas, Christos Savopoulos
Endocrines. 2022; 3(1): 43
[Pubmed]  [Google Scholar] [DOI]
2 Non-fixed combination perindopril+moxonidine for blood pressure control in hypertensive patients with metabolic syndrome
S.V. Nedogoda, E.V. Chumachek, A.A. Ledyaeva, V.V. Tsoma, D.S. Vlasov, O.I. Bychkova
Kardiologiya i serdechno-sosudistaya khirurgiya. 2021; 14(2): 208
[Pubmed]  [Google Scholar] [DOI]
3 Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review)
O. D. Ostroumova, I. A. Alyautdinova, S. N. Litvinova, A. V. Arablinskij, A. A. Kirichenko
Rational Pharmacotherapy in Cardiology. 2021; 17(1): 124
[Pubmed]  [Google Scholar] [DOI]
4 Effective strategies for prevention of cardiovascular complications in elderly patients with arterial hypertension and obesity (clinical example)
A. P. Pereverzev, O. D. Ostroumova, E. V. Mironova
Medical alphabet. 2020; (21): 10
[Pubmed]  [Google Scholar] [DOI]
5 The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-a
Aaron L. Magno, Lakshini Y. Herat, Márcio G. Kiuchi, Markus P. Schlaich, Natalie C. Ward, Vance B. Matthews
Journal of Clinical Medicine. 2020; 9(9): 2764
[Pubmed]  [Google Scholar] [DOI]
6 Investigation of the vasorelaxant effects of moxonidine and its relaxation mechanism on the human radial artery when used as a coronary bypass graft
Bulent Sarac,Ozge Korkmaz,Ahmet Altun,Ihsan Bagcivan,Sabahattin Göksel,Sahin Yildirim,Ocal Berkan
Interactive CardioVascular and Thoracic Surgery. 2015; 21(3): 342
[Pubmed]  [Google Scholar] [DOI]


Read this article